DTC
Deep Track Capital Portfolio holdings
AUM
$3.11B
This Quarter Return
+3.12%
1 Year Return
+13.6%
3 Year Return
+265.73%
5 Year Return
–
10 Year Return
–
AUM
$1.35B
AUM Growth
–
Cap. Flow
+$1.35B
Cap. Flow
% of AUM
100%
Top 10 Holdings %
Top 10 Hldgs %
44.69%
Holding
53
New
49
Increased
–
Reduced
–
Closed
–
Top Buys
| 1 |
Keros Therapeutics
KROS
|
$76.1M |
| 2 |
Travere Therapeutics
TVTX
|
$76M |
| 3 |
BCYC
Bicycle Therapeutics
BCYC
|
$67M |
| 4 |
ISEE
IVERIC bio, Inc. Common Stock
ISEE
|
$66.9M |
| 5 |
Jazz Pharmaceuticals
JAZZ
|
$63.7M |
Top Sells
No sells this quarter
Sector Composition
| 1 | Healthcare | 99.89% |
| 2 | Real Estate | 0.11% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
51
Alnylam Pharmaceuticals
ALNY
$58.5B
| – | – | 0 | – | – |
|
52
BridgeBio Pharma
BBIO
$9.89B
| – | – | 0 | – | – |
|
53
Nektar Therapeutics
NKTR
$568M
| – | – | 0 | – | – |
|